• Home
  • Covid-19
  • Aspen: Licencing rights to produce own Covid vaccine
Aspen:  Licencing rights to produce own Covid vaccine

Aspen: Licencing rights to produce own Covid vaccine

Aspen Pharmacare said that licensing rights to produce a COVID-19 vaccine under its own label was a huge boost for the African continent.

It will be called Aspenovax and distributed to countries on the African continent.

 

Aspen has finalised initial terms with Johnson & Johnson that will see the company produce coronavirus vaccines using a drug substance supplied by J&J in the near future.

The company will now have control over the allocation and distribution of the COVID-19 jabs it produces, something previously decided by Johnson & Johnson.

“It’s also a significant development in addressing the inequality, unevenness of vaccine distribution that has been attributable to the African continent. This will allow Africa to have its own vaccine now,” said Aspen senior executive, Doctor Stavros Nicolaou.|

 

Nicolaou said that the deal with J&J may also include any new versions of the drug substance, such as those developed for new variants or as a different formulation for booster shots.


React

Share

Comments


Trending News

More News

About Tame Times

Tame Communications (known as tame TIMES) was established in 2009. This long-established popular community title includes the key shopping centres:  Alberton City, Mal...

Get in Touch